Covid-19 Pandemic: European Union approves Pfizer’s Kovid vaccine for children aged 5 to 11

Covid Vaccine: The European Medicines Agency on Thursday approved Pfizer’s anti-Covid-19 vaccine for children aged 5 to 11 years.  With this, the way has been cleared for the Kovid vaccination of millions of school children amid the increase in new cases of corona virus in Europe. 

According to the EMA, children in the age group of 5 to 11 years will be given two injections with a third of the dose at an interval of three weeks. This is the first time that the EMA has approved a Kovid vaccine for the vaccination of children. In the vaccine trial, in a study conducted on about 2,000 children aged 5 to 11 years, this vaccine was 90.7 percent effective. On the other hand, post-vaccination side effects include pain at the injection site, fatigue, headache, muscle aches and chills.

Interpol: Interpol elected UAE official as its President, Indian officials also elected in Apex Committee

Italy COVID-19: Restrictions will be imposed on people who do not get vaccinated in Italy, vaccination certificate will have to be shown in hotels and cinema halls



Scroll to Top